303 related articles for article (PubMed ID: 14727564)
1. [Preferential distal muscle involvement in case of oculopharyngeal muscular dystrophy with (GCG) 13 expansion].
Nakashima D; Nakajima H; Ishida S; Sugino M; Kimura F; Hanafusa T
Rinsho Shinkeigaku; 2003 Sep; 43(9):560-3. PubMed ID: 14727564
[TBL] [Abstract][Full Text] [Related]
2. [Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene].
Pou Serradell A; Lloreta Trull J; Corominas Torres JM; Hammouda EH; Urtizberea JA; Richard P; Brais B
Neurologia; 2004 Jun; 19(5):239-47. PubMed ID: 15150706
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel mutation in a Korean patient with oculopharyngeal muscular dystrophy.
Bae JS; Ki CS; Kim JW; Kim BJ
J Clin Neurosci; 2007 Jan; 14(1):89-92. PubMed ID: 17138075
[TBL] [Abstract][Full Text] [Related]
4. Study of a Taiwanese family with oculopharyngeal muscular dystrophy.
Kuo HC; Chen CM; Lee-Chen GJ; Hu FJ; Chu CC; Liou CW; Huang CC
J Neurol Sci; 2009 Mar; 278(1-2):21-4. PubMed ID: 19101703
[TBL] [Abstract][Full Text] [Related]
5. Oculopharyngeal muscular dystrophy (OPMD) due to a small duplication in the PABPN1 gene.
van der Sluijs BM; van Engelen BG; Hoefsloot LH
Hum Mutat; 2003 May; 21(5):553. PubMed ID: 12673802
[TBL] [Abstract][Full Text] [Related]
6. (GCG)11 founder mutation in the PABPN1 gene of OPMD Uruguayan families.
Rodríguez M; Camejo C; Bertoni B; Braida C; Rodríguez MM; Brais B; Medici M; Roche L
Neuromuscul Disord; 2005 Feb; 15(2):185-90. PubMed ID: 15694141
[TBL] [Abstract][Full Text] [Related]
7. Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice.
Davies JE; Wang L; Garcia-Oroz L; Cook LJ; Vacher C; O'Donovan DG; Rubinsztein DC
Nat Med; 2005 Jun; 11(6):672-7. PubMed ID: 15864313
[TBL] [Abstract][Full Text] [Related]
8. Two cases of oculopharyngeal muscular dystrophy (OPMD) with the rare PABPN1 c.35G>C; p.Gly12Ala point mutation.
Robinson DO; Hilton-Jones D; Mansfield D; Hildebrand GD; Marks S; Mechan D; Ramsay J
Neuromuscul Disord; 2011 Nov; 21(11):809-11. PubMed ID: 21742497
[TBL] [Abstract][Full Text] [Related]
9. Oculopharyngeal muscular dystrophy with PABPN1 mutation in a Chinese Malaysian woman.
Goh KJ; Wong KT; Nishino I; Minami N; Nonaka I
Neuromuscul Disord; 2005 Mar; 15(3):262-4. PubMed ID: 15725589
[TBL] [Abstract][Full Text] [Related]
10. Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder.
Davies JE; Berger Z; Rubinsztein DC
Int J Biochem Cell Biol; 2006; 38(9):1457-62. PubMed ID: 16530457
[TBL] [Abstract][Full Text] [Related]
11. Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy.
Messaed C; Dion PA; Abu-Baker A; Rochefort D; Laganiere J; Brais B; Rouleau GA
Neurobiol Dis; 2007 Jun; 26(3):546-57. PubMed ID: 17418585
[TBL] [Abstract][Full Text] [Related]
12. A de novo PABPN1 germline mutation in a patient with oculopharyngeal muscular dystrophy.
Gürtler N; Plasilova M; Podvinec M; Boesch N; Müller H; Heinimann K
Laryngoscope; 2006 Jan; 116(1):111-4. PubMed ID: 16481821
[TBL] [Abstract][Full Text] [Related]
13. Premature proliferative arrest of cricopharyngeal myoblasts in oculo-pharyngeal muscular dystrophy: Therapeutic perspectives of autologous myoblast transplantation.
Périé S; Mamchaoui K; Mouly V; Blot S; Bouazza B; Thornell LE; St Guily JL; Butler-Browne G
Neuromuscul Disord; 2006 Nov; 16(11):770-81. PubMed ID: 17005403
[TBL] [Abstract][Full Text] [Related]
14. [The clinical-genealogic and molecular-genetic characteristics of oculopharyngeal muscular dystrophy in the Republic of Sakha (Yakutia)].
Maksimova NR; Nikolaeva IA; Korotkov MN; Ikeuchi T; Onodera O; Nishizava M; Stepanova SK; Kurtanov KhA; Sukhomiasova AL; Nogovitsyna AN; Gurinova EE; Stepanov VA; Puzyrev VP
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):52-60. PubMed ID: 18577936
[TBL] [Abstract][Full Text] [Related]
15. Oculopharyngeal muscular dystrophy: phenotypic and genotypic characteristics of 9 Polish patients.
Nadaj-Pakleza A; Richard P; Lusakowska A; Gajewska J; Jamrozik Z; Kostera-Pruszczyk A; Kwieciński H; Kamińska A
Neurol Neurochir Pol; 2009; 43(2):113-20. PubMed ID: 19484687
[TBL] [Abstract][Full Text] [Related]
16. Two different PABPN1 expanded alleles in a Mexican population with oculopharyngeal muscular dystrophy arising from independent founder effects.
Rivera D; Mejia-Lopez H; Pompa-Mera EN; Villanueva-Mendoza C; Nava-Castañeda A; Garnica-Hayashi L; Cuevas-Covarrubias S; Zenteno JC
Br J Ophthalmol; 2008 Jul; 92(7):998-1002. PubMed ID: 18577654
[TBL] [Abstract][Full Text] [Related]
17. Variability of the recessive oculopharyngeal muscular dystrophy phenotype.
Semmler A; Kress W; Vielhaber S; Schröder R; Kornblum C
Muscle Nerve; 2007 May; 35(5):681-4. PubMed ID: 17206657
[TBL] [Abstract][Full Text] [Related]
18. Mutation and haplotype analysis of oculopharyngeal muscular dystrophy in Thai patients.
Pulkes T; Papsing C; Busabaratana M; Dejthevaporn C; Witoonpanich R
J Clin Neurosci; 2011 May; 18(5):674-7. PubMed ID: 21316245
[TBL] [Abstract][Full Text] [Related]
19. Oculopharyngeal muscular dystrophy --an under-diagnosed disease in China? Report a China-born Chinese with PABPN1 mutation and epidemiology review of the literature.
Chien YY
J Formos Med Assoc; 2012 Jul; 111(7):397-402. PubMed ID: 22817818
[TBL] [Abstract][Full Text] [Related]
20. Oculopharyngeal muscular dystrophy with limb girdle weakness as major complaint.
Van Der Sluijs BM; Hoefsloot LH; Padberg GW; Van Der Maarel SM; Van Engelen BG
J Neurol; 2003 Nov; 250(11):1307-12. PubMed ID: 14648146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
